North America Surgical Stapling Devices Market Forecast to 2028 -Regional Analysis

The North America surgical stapling devices market was valued at US$ 1,962.94 million in 2022 and is projected to reach US$ 3,208.08 million by 2028. It is estimated to grow at a CAGR of 8.5% from 2022 to 2028.

New Product Launches and Strategic Collaborations Fuel North America Surgical Stapling Devices Market Growth

A significant rise in the number of surgical procedures performed at hospitals has compelled medical device manufacturers to develop and launch new products and obtain regulatory approvals for them. Major companies in the surgical stapling devices market allocate significant resources to research and development activities to come up with new offerings. For instance, In October 2022, Teleflex Incorporated completed the acquisition of Standard Bariatrics, Inc., which has commercialized an innovative powered stapling technology for bariatric surgery. Teleflex acquired Standard Bariatrics for US$ 170 million at closing, with additional consideration of up to US$ 130 million that is payable upon achieving certain commercial milestones. Similarly, in June 2022, Ethicon, a part of Johnson & Johnson MedTech, launched ECHELON 3000 Stapler in the US. It is a digitally enabled device that provides surgeons with simple, one-handed powered articulation to help address the unique needs of their patients. Designed with a 39% greater jaw aperture and a 27% larger articulation span, ECHELON 3000 gives surgeons better access and control over each transection, even in tight spaces and on challenging tissue. Combined with software that provides real-time haptic and audible device feedback, these features enable surgeons to make critical adjustments during procedures. An increase in the number of developments and launches of such innovative products, along with business acquisitions and collaborations, boosts the growth of the North America surgical stapling devices market.

North America Surgical Stapling Devices Market Overview

The North America surgical stapling devices market is segmented into the US, Canada, and Mexico. The US is expected to be the largest contributor to the market in this region. The market growth in North America is ascribed to the growing geriatric population, favorable healthcare reforms, and surgical procedures performed in large numbers every year. According to the Journal of Thoracic Disease, ~530,000 general thoracic surgeries are performed yearly in the US by ~4,000 cardiothoracic surgeons. According to the American Joint Replacement Registry (AJRR), it is estimated that ~3.48 million people would require knee replacement by 2030. The estimates are calculated by considering the baby boomers reaching old age in the US. Total joint replacement (TJR) is one of the most performed elective surgeries in the US. According to a new study presented at the 2018 Annual Meeting of the American Academy of Orthopedic Surgeons (AAOS), the number of primary total hip replacement (THR) procedures is projected to grow by 171% by 2030, while the primary total knee replacement (TKR) procedures would increase by ~189%, reaching the count of 635,000 and 1.28 million procedures, respectively. A surge in demand for advanced surgical methods and tools such as biocompatible staples with better leakage protection in different types of surgeries favors the growth of the surgical stapling devices market in the US.

North America Surgical Stapling Devices Market Revenue and Forecast to 2028 (US$ Million)

North America Surgical Stapling Devices Market Segmentation

The North America surgical stapling devices market is segmented on the basis of product, type, application, end user, and country. Based on product, the market is segmented into powered surgical staplers and manual surgical staplers. The powered surgical staplers segment held a larger market share in 2022.

Based on type, the North America surgical stapling devices market is segmented into disposable surgical staplers and reusable surgical staplers. The disposable surgical staple segment accounted for a larger market share in 2022.

Based on application, the North America surgical stapling devices market is segmented into orthopedic surgery, endoscopic surgery, cardiac and thoracic surgery, abdominal and pelvic surgery, and others. The orthopedic surgery segment registered the largest market share in 2022.

Based on end user, the North America surgical stapling devices market is segmented into hospitals and ambulatory surgical centers. The hospitals segment accounted for a larger market share in 2022.

Based on country, the North America surgical stapling devices market is segmented into the US, Canada, and Mexico. The US dominated the market in this region in 2022.

3M Co, B. Braun SE, Conmed Corp, Ethicon USA LLC, Intuitive Surgical Inc, and Medtronic Plc are the leading companies operating in the North America surgical stapling devices market.